• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Mpox Recrudescence after SARS-CoV-2 Coinfection in a Patient with AIDS.一名艾滋病患者在感染新型冠状病毒后出现猴痘复发
Am J Trop Med Hyg. 2024 Dec 31;112(3):677-681. doi: 10.4269/ajtmh.24-0304. Print 2025 Mar 5.
2
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
3
Therapeutics for treating mpox in humans.人类天花治疗方法。
Cochrane Database Syst Rev. 2023 Mar 14;3(3):CD015769. doi: 10.1002/14651858.CD015769.
4
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
5
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.奈玛特韦片/利托那韦片组合包装用于 COVID-19 的预防和治疗。
Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD015395. doi: 10.1002/14651858.CD015395.pub2.
6
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
7
Epidemiology and phylogenomic characterisation of two distinct mpox outbreaks in Kinshasa, DR Congo, involving a new subclade Ia lineage: a retrospective, observational study.刚果民主共和国金沙萨两起不同的猴痘疫情的流行病学和系统基因组特征分析,涉及一个新的Ia亚分支谱系:一项回顾性观察研究
Lancet. 2025 Jul 5;406(10498):63-75. doi: 10.1016/S0140-6736(25)00294-6.
8
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.奈玛特韦/利托那韦片用于 COVID-19 的预防和治疗。
Cochrane Database Syst Rev. 2023 Nov 30;11(11):CD015395. doi: 10.1002/14651858.CD015395.pub3.
9
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
10
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19.SARS-CoV-2 中和单克隆抗体预防 COVID-19。
Cochrane Database Syst Rev. 2022 Jun 17;6(6):CD014945. doi: 10.1002/14651858.CD014945.pub2.

本文引用的文献

1
Immune reconstitution inflammatory syndrome due to monkeypox in two patients with AIDS.两名艾滋病患者因猴痘引发免疫重建炎症综合征。
AIDS. 2023 Jun 1;37(7):1187-1188. doi: 10.1097/QAD.0000000000003541.
2
Monkeypox (mpox) in immunosuppressed patients.免疫抑制患者中的猴痘(mpox)。
F1000Res. 2023 Feb 2;12:127. doi: 10.12688/f1000research.130272.2. eCollection 2023.
3
A Case of Mpox Reinfection.一例猴痘再感染病例。
Clin Infect Dis. 2023 Jul 5;77(1):135-137. doi: 10.1093/cid/ciad147.
4
Mpox in people with advanced HIV infection: a global case series.晚期HIV感染者中的猴痘:一项全球病例系列研究。
Lancet. 2023 Mar 18;401(10380):939-949. doi: 10.1016/S0140-6736(23)00273-8. Epub 2023 Feb 21.
5
COVID-19 infection and vaccines: potential triggers of Herpesviridae reactivation.COVID-19 感染和疫苗:疱疹病毒科激活的潜在触发因素。
An Bras Dermatol. 2023 May-Jun;98(3):347-354. doi: 10.1016/j.abd.2022.09.004. Epub 2023 Feb 10.
6
Case of apparent mpox reinfection.疑似猴痘再感染病例。
Sex Transm Infect. 2023 Jun;99(4):283-284. doi: 10.1136/sextrans-2022-055736. Epub 2023 Jan 27.
7
Clinical Characteristics of Human Mpox (Monkeypox) in 2022: A Systematic Review and Meta-Analysis.2022年人类猴痘的临床特征:系统评价与荟萃分析
Pathogens. 2023 Jan 15;12(1):146. doi: 10.3390/pathogens12010146.
8
Disseminated Tuberculosis Post COVID-19 Infection: A Case Report.新冠病毒感染后播散性肺结核:一例报告
Cureus. 2022 Nov 14;14(11):e31489. doi: 10.7759/cureus.31489. eCollection 2022 Nov.
9
Epidemiological and clinical characteristics of patients with monkeypox in the GeoSentinel Network: a cross-sectional study.猴痘在 GeoSentinel 网络中的患者的流行病学和临床特征:一项横断面研究。
Lancet Infect Dis. 2023 Feb;23(2):196-206. doi: 10.1016/S1473-3099(22)00651-X. Epub 2022 Oct 7.
10
HIV and Sexually Transmitted Infections Among Persons with Monkeypox - Eight U.S. Jurisdictions, May 17-July 22, 2022.2022 年 5 月 17 日至 7 月 22 日,美国八个司法管辖区内猴痘患者中的艾滋病毒和性传播感染情况。
MMWR Morb Mortal Wkly Rep. 2022 Sep 9;71(36):1141-1147. doi: 10.15585/mmwr.mm7136a1.

一名艾滋病患者在感染新型冠状病毒后出现猴痘复发

Mpox Recrudescence after SARS-CoV-2 Coinfection in a Patient with AIDS.

作者信息

Liu Yaqing, Zou Shi, Song Shihui, Wan Yingcai, Wu Jianbo, Luo Mingqi, Guo Wei, Liang Ke

机构信息

Department of Infectious Diseases, Zhongnan Hospital of Wuhan University, Wuhan, China.

Wuhan Research Center for Infectious Diseases and Cancer, Chinese Academy of Medical Sciences, Wuhan, China.

出版信息

Am J Trop Med Hyg. 2024 Dec 31;112(3):677-681. doi: 10.4269/ajtmh.24-0304. Print 2025 Mar 5.

DOI:10.4269/ajtmh.24-0304
PMID:39742525
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11884265/
Abstract

People living with HIV (PLWH) are known to exhibit more severe or prolonged symptoms of mpox (formerly monkeypox). However, the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on PLWH with mpox has not been adequately described. We report a case of mpox in an AIDS patient who had recurrent symptoms due to SARS-CoV-2 infection. The patient presented with a low CD4+ lymphocyte count (CD4 count) without antiretroviral therapy (ART) and suffered from severe mpox. The ART was initiated 17 days after the diagnosis of mpox, and the patient's skin lesions began crusting after 1 week of ART. However, after a SARS-CoV-2 infection, the mpox flared up again. The patient presented with more severe symptoms than those during the initial bout and with rectal involvement. We speculate that SARS-CoV-2 infection might cause a recrudescence of mpox in AIDS patients, which requires further investigation.

摘要

已知人类免疫缺陷病毒感染者(PLWH)会出现更严重或持续时间更长的猴痘(原称猴天花)症状。然而,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)对合并猴痘的PLWH的影响尚未得到充分描述。我们报告了一例艾滋病患者的猴痘病例,该患者因SARS-CoV-2感染出现反复症状。患者在未接受抗逆转录病毒治疗(ART)的情况下CD4+淋巴细胞计数较低(CD4计数),并患有严重猴痘。在猴痘诊断17天后开始ART,ART治疗1周后患者的皮肤病变开始结痂。然而,在感染SARS-CoV-2后,猴痘再次发作。患者出现了比初次发作时更严重的症状,且直肠受累。我们推测SARS-CoV-2感染可能导致艾滋病患者猴痘复发,这需要进一步研究。